Cwm, LLC Natera, Inc. Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Cwm, LLC holds 15,441 shares of NTRA stock, worth $2.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

15,441

Previous 7,035 119.49%

Holding current value

$2.6 Million

Previous $762,000 157.22%

% of portfolio

0.01%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$97.75 - $129.67 $821,686 - $1.09 Million	8,406 Added 119.49%	15,441 $1.96 Million
Q2 2024 Jul 09, 2024	BUY	$85.28 - $112.6 $397,404 - $524,716	4,660 Added 196.21%	7,035 $762,000
Q1 2024 Apr 05, 2024	BUY	$59.21 - $92.9 $30,078 - $47,193	508 Added 27.21%	2,375 $217,000
Q4 2023 Feb 01, 2024	BUY	$37.55 - $62.64 $20,652 - $34,452	550 Added 41.76%	1,867 $117,000
Q3 2023 Oct 11, 2023	BUY	$43.4 - $62.52 $39,537 - $56,955	911 Added 224.38%	1,317 $58,000
Q2 2023 Aug 03, 2023	BUY	$47.08 - $55.16 $2,401 - $2,813	51 Added 14.37%	406 $20,000
Q1 2023 Apr 28, 2023	BUY	$36.57 - $58.29 $2,340 - $3,730	64 Added 21.99%	355 $20,000
Q4 2022 Feb 01, 2023	BUY	$34.17 - $47.91 $2,460 - $3,449	72 Added 32.88%	291 $12,000
Q3 2022 Oct 27, 2022	BUY	$36.93 - $56.68 $1,772 - $2,720	48 Added 28.07%	219 $10,000
Q2 2022 Jul 28, 2022	SELL	$28.13 - $44.54 $14,768 - $23,383	-525 Reduced 75.43%	171 $6,000
Q1 2022 Apr 21, 2022	BUY	$30.32 - $91.33 $19,253 - $57,994	635 Added 1040.98%	696 $28,000
Q4 2021 Jan 31, 2022	BUY	$86.26 - $119.0 $5,261 - $7,259	61 New	61 $6,000

Others Institutions Holding NTRA

# of Institutions

528

Shares Held

119M

Call Options Held

308K

Put Options Held

191K

View Full List

About Natera, Inc.

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

More about NTRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account